Sanofi Genzyme goes to Phase III with Neuromuscular Disease
Sanofi posts 'better than expected' Q2 results, analysts say
Sanofi su LinkedIn: Malattia di Fabry
Sanofi US on X: "Have you heard of #Pompe disease? Just knowing the symptoms of this #RareDisease could help reduce the time to diagnosis. Share with the hashtag #GreaterThanPompe to raise awareness
Pompe - Climbing Stairs
Sanofi's enzyme replacement therapy available on NHS to Pompe disease patients - PMLiVE
Sanofi Genzyme: COMET Phase 3 Trial - Results | Pompe Support Network
Sanofi CEO does not rule out future Pompe BD despite FTC moves
Sanofi Secures FDA Nod in Late-Onset Pompe Disease | BioSpace
FDA approves Sanofi's Nexviazyme for Pompe disease treatment
Sanofi signs agreement worth up to $750m for Maze's Pompe disease drug
Sanofi Genzyme goes to Phase III with Neuromuscular Disease
BioCentury - Aug. 6 Quick Takes: Sanofi gains FDA approval for Pompe therapy
U.S. FDA approves another Sanofi drug for rare muscle disorder Pompe disease | Reuters
DottNet - Malattia di Pompe: priority review della FDA per avalglucosidasi alfa
Sanofi extends its Pompe range with first Nexviazyme OK | pharmaphorum
Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug - MedCity News
Sanofi Aventis – GM IMPIANTI
Sanofi stock rises on licensing deal with Maze for Pompe disease drug | Seeking Alpha
FDA approves Sanofi's Nexviazyme for late-onset Pompe disease - Drug Discovery and Development
Malattia di Pompe, via libera europeo all'uso di avalglucosidasi alfa come nuovo potenziale standard di cura - AboutPharma
Sanofi Launched Advanced Treatment for Pompe Disease | CCI France Taiwan
Sanofi drops acquisition of Maze's Pompe Disease drug after FTC challenge - PharmaLive
Sanofi coughs up $180M to settle Pompe disease royalty payment dispute | Fierce Pharma
Sanofi termina l'accordo sulla licenza del farmaco dopo le obiezioni della FTC statunitense -11 dicembre 2023 alle 22:33 | MarketScreener
Sanofi: forte crescita delle vendite nel 2021 - Tecnomedicina
Enzyme Replacement Therapy (ERT) – Pompe Disease (Glycogen Storage Disease 2)
MeetSanofi | Malattia di Pompe, la qualità della vita passa anche dal cibo e dalla tecnologia
International Pompe Day 2019 – Ricette per stare meglio – Associazione Italiana Glicogenosi
